Ondine Biomedical Inc. (LON:OBI – Get Free Report)’s share price fell 4% on Tuesday . The company traded as low as GBX 6 ($0.08) and last traded at GBX 6 ($0.08). 26,019 shares changed hands during trading, a decline of 90% from the average session volume of 258,805 shares. The stock had previously closed at GBX 6.25 ($0.08).
Ondine Biomedical Stock Performance
The stock’s fifty day moving average price is GBX 6.73 and its two-hundred day moving average price is GBX 7.25. The company has a debt-to-equity ratio of 1,847.37, a quick ratio of 8.26 and a current ratio of 0.80. The company has a market cap of £17.68 million, a P/E ratio of -208.33 and a beta of 0.10.
About Ondine Biomedical
Ondine Biomedical Inc, a Life sciences company, engages in the research, development, and commercialization of antimicrobial photodisinfection therapies in Canada and internationally. Its product platform is Photodisinfection, a topical light-based antimicrobial technology that eliminates harmful pathogens.
Featured Stories
- Five stocks we like better than Ondine Biomedical
- Stock Average Calculator
- Taiwan Semiconductor Stock: Buy Now or Wait for Earnings?
- What Are Dividends? Buy the Best Dividend Stocks
- Abbott’s Growth and Dividends Make It a Smart Portfolio Pick
- Best Aerospace Stocks Investing
- Citigroup Faces Growing Troubles: Could the Industry Be at Risk?
Receive News & Ratings for Ondine Biomedical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ondine Biomedical and related companies with MarketBeat.com's FREE daily email newsletter.
